Enovis Corp ENOV
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Enovis to Host Third Quarter 2026 Results Conference Call on November 5th
-
Enovis becomes first multi-registry industry sponsor of AAOS Registry Program
-
eCential Robotics Announces Binding Offer from Enovis
-
Enovis Invests in Innovation with Binding Offer to Acquire eCential Robotics, a Leading Developer of Enabling Technologies and Surgical Robotics
-
Enovis to Participate in the 2026 Wells Fargo Healthcare Conference
-
Enovis Announces Second Quarter 2026 Results
Trading Information
- Previous Close Price
- $21.16
- Day Range
- $20.61–22.13
- 52-Week Range
- $16.70–33.13
- Bid/Ask
- $18.47 / $22.47
- Shares Outstanding
- 57.67M
- Market Cap
- $1.24B
- Volume/Avg
- 4 / 2M
Key Statistics
- Price/Earnings (Normalized)
- 6.19
- Price/Sales
- 0.54
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Enovis Corp is a medical technology manufacturer and distributor of medical devices used in reconstructive surgery, rehabilitation, pain management, and physical therapy. Its products support patient care from injury prevention through post-surgical or post-injury rehabilitation and treatment of degenerative conditions. The company's reportable segments include Prevention & Recovery and Reconstructive segments. The majority of revenueis derived from the Prevention & Recovery segment, which includes products that are used by orthopedic specialists, primary care physicians, physical therapists, chiropractors, athletic trainers and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformitiesand sports-related injuries.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 7,802
- Website
- https://www.enovis.com
Valuation
|
Metric
|
ENOV
|
|---|---|
Price/Earnings (Normalized) | 6.19 |
Price/Book Value | 0.84 |
Price/Sales | 0.54 |
Price/Cash Flow | 4.99 |
Price/Earnings
ENOV
Financial Strength
|
Metric
|
ENOV
|
|---|---|
Quick Ratio | 0.74 |
Current Ratio | 1.98 |
Interest Coverage | −30.84 |
Quick Ratio
ENOV
Profitability
|
Metric
|
ENOV
|
|---|---|
Return on Assets (Normalized) | 0.61% |
Return on Equity (Normalized) | 1.40% |
Return on Invested Capital (Normalized) | 1.61% |
Return on Assets
ENOV
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|p#$#?y | LOCK|W^%% | $178B | |||
| Medtronic PLC
MDT
| LOCK|%r!ljQY | LOCK|Fkjl | $120B | |||
| Stryker Corp
SYK
| LOCK|$T$m?x@ | LOCK|!QT | $116B | |||
| Boston Scientific Corp
BSX
| LOCK|<%Wlfd | LOCK|vw<@x | $65B | |||
| Edwards Lifesciences Corp
EW
| LOCK|q<ry^wfF | LOCK|jm?p> | $52B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|#&RM&# | LOCK|c% | $32B | |||
| DexCom Inc
DXCM
| LOCK|zCcNz#l | LOCK|%zT< | $30B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|Dhy | LOCK|>@$ | $26B | |||
| Steris PLC
STE
| LOCK|myv>DmW | LOCK|#QS@k | $22B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|%XntL!>$ | LOCK|bk$ | $18B |
United States